Dr. George Birkmayer
Professor George Birkmayer, M.D., Ph.D., developer of ENADA and ENADAlet stabilized NADH, was the first to identify the importance of NADH in cellular development and energy transmissions for all bodily functions and organs. He founded Menuco Corporation in 1995 and is a world-renowned biochemical researcher and Medical Director of the Birkmayer Institute for Parkinson’s Therapy, which has treated thousands of patients suffering from Parkinson’s disease after having studied the biochemical connections between Parkinsons and NADH.
Additionally, Dr. George Birkmayer is a Professor at the University of Graz, Austria and head of its Division of Neurochemistry at the Department of Medical Chemistry. He is also visiting professor at the University of Beijing and Canton , China and Secretary General of the International Academy of Tumor Marker Oncology in New York . He is the European Editor of the Journal of Tumor Market Oncology, and a member of the editorial board of the Journal of Experimental and Clinical Cancer Research as well as additional scientific journals. He is a member of several international scientific societies including the New Academy of Sciences and the American Association of Cancer Research. He is also a Fellow of the American College of Nutrition.
ENADA is proud to be a leading supplier of ENADA NADH Supplements and energy pills. The newly branded Co-E1 NADH dietary supplement can help individuals suffering from fatigue disorders, energy deficiencies, as well as other ailments. Athletes, mature individuals, or anybody needing a boost in energy or alertness may benefit from these NADH Supplements. ENADA also manufactures the easily digestible sublingual supplement known for its ability to be absorbed by the body quickly. Always consult a physician for guidance on any medical condition or medical treatment.
Co-E1 NADH, ENADA NADH, CoQ10, ENADAler